Thursday, October 15, 2009

FDA Panel Likes Acorda's Multiple Sclerosis Drug - Wall Street Journal (blog)


FDA Panel Likes Acorda's Multiple Sclerosis Drug
Wall Street Journal (blog)
Shares of Acorda Therapeutics, a small company that's developing the drug, rose more than 40% in after-hours trading. As often happens when a small ...

and more »

No comments:

Post a Comment